Responses
Section 2: Selection, procurement and distribution
3PC-071 Fully automated central intravenous additive service (CIVAS): a 12 month analysis of performances and impact of COVID-19 on sterile antibiotic production
Compose a Response to This Article
Other responses
No responses have been published for this article.